Quick Answer
SUPERNUS PHARMACEUTICALS, INC. reported Shares Outstanding of 57.46 million shares for fiscal year 2025.
SUPERNUS PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 57.46M | +3.1% |
| 2024 | 55.74M | +1.9% |
| 2023 | 54.72M | +0.9% |
| 2022 | 54.25M | +1.9% |
| 2021 | 53.26M | +0.7% |
| 2020 | 52.87M | +0.6% |
| 2019 | 52.53M | +0.4% |
| 2018 | 52.32M | +2.0% |
| 2017 | 51.31M | +2.7% |
| 2016 | 49.97M | +2.0% |
| 2015 | 49.00M | +14.0% |
| 2014 | 42.97M | +7.5% |
| 2013 | 39.98M | +30.6% |
| 2012 | 30.62M | +1742.1% |
| 2011 | 1.66M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 57.12M | +3.4% | +1.8% |
| June 30, 2025 | 56.12M | +1.9% | +0.2% |
| March 31, 2025 | 55.99M | +2.3% | +0.4% |
| December 31, 2024 | 55.74M | +1.9% | +0.9% |
| September 30, 2024 | 55.22M | +1.8% | +0.3% |
| June 30, 2024 | 55.05M | +1.5% | +0.6% |
| March 31, 2024 | 54.72M | +0.9% | +0.0% |
| December 31, 2023 | 54.72M | +0.9% | +0.9% |
- SUPERNUS PHARMACEUTICALS, INC. showed an increase of +3.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2011–2025 period, SUPERNUS PHARMACEUTICALS, INC.’s shares outstanding has grown by 3356.5% (from 1.66 million shares to 57.46 million shares).
- The most recent figure is from SUPERNUS PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: